106 related articles for article (PubMed ID: 3056532)
1. Neuroblastoma today.
Ferster A; Schots R; Maurus R; Otten J
Biomed Pharmacother; 1988; 42(4):247-55. PubMed ID: 3056532
[TBL] [Abstract][Full Text] [Related]
2. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
[TBL] [Abstract][Full Text] [Related]
3. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
4. [Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine].
Klingebiel T; Feine U; Niethammer D; Müller-Schauenburg W; Schwabe D; Maul FD; Gerein V; Fischer M; Gahr M; Kraz K
Klin Padiatr; 1986; 198(3):230-6. PubMed ID: 3723987
[TBL] [Abstract][Full Text] [Related]
5. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
[TBL] [Abstract][Full Text] [Related]
6. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
7. [Metastatic neuroblastoma: consolidation treatment with 2 courses of high-dose chemotherapy followed by a bone marrow autograft].
Hartmann O; Benhamou E; Beaujean F; Kalifa C; Lejars O; Patte C; Behard C; Flamant F; Thyss A; Deville A
Bull Cancer; 1988; 75(1):119-23. PubMed ID: 3282574
[TBL] [Abstract][Full Text] [Related]
8. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
[TBL] [Abstract][Full Text] [Related]
9. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
[TBL] [Abstract][Full Text] [Related]
10. Iodine-125-MIBG therapy for neuroblastoma.
Hoefnagel CA; Smets L; Voûte PA; de Kraku J
J Nucl Med; 1991 Feb; 32(2):361-2. PubMed ID: 1992043
[No Abstract] [Full Text] [Related]
11. Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany.
Burkhardt-Hammer T; Spix C; Brenner H; Kaatsch P; Berthold F; Hero B; Michaelis J
Med Pediatr Oncol; 2002 Sep; 39(3):156-62. PubMed ID: 12210443
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow transplantation for very bad prognosis neuroblastoma.
Philip T; Biron P; Philip I; Favrot M; Bernard JL; Zucker JM; Lutz B; Plouvier E; Rebattu P; Carton M
Prog Clin Biol Res; 1985; 175():569-86. PubMed ID: 3887433
[No Abstract] [Full Text] [Related]
13. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
14. [Intensive chemotherapy and bone marrow grafting during the consolidation phase of stage IV neuroblastoma].
Philip T; Zucker JM; Bernard JL; Bordigoni P; Souillet G; Robert A; Roche H; Philip I; Chauvin F; Favrot MC
Bull Cancer; 1988; 75(1):113-7. PubMed ID: 3282573
[TBL] [Abstract][Full Text] [Related]
15. Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.
Cheung NK; Guo HF; Heller G; Cheung IY
Clin Cancer Res; 2000 Jul; 6(7):2653-60. PubMed ID: 10914706
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system relapse following bone marrow transplantation in stage IV neuroblastoma.
Palasis S; Morris J; Egelhoff JC
Pediatr Hematol Oncol; 1999; 16(5):443-52. PubMed ID: 10505321
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric models and S factors for radiation doses to the bladder wall in children receiving therapeutic iodine-131-MIBG.
Bolster AA; Hilditch TE; Wheldon TE
J Nucl Med; 1995 Aug; 36(8):1530-1. PubMed ID: 7629603
[No Abstract] [Full Text] [Related]
18. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
19. [Focus on neuroblastoma in 1987. 2: Treatment].
Philip T; Kremens B; Chappuis JP
Pediatrie; 1987; 42(4):231-9. PubMed ID: 3313264
[TBL] [Abstract][Full Text] [Related]
20. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]